Patent Assignment
Reel/Frame 051946/0822
Assignment of Assignor's Interest
Recorded: 2020-02-27
Pages: 8
Assignor
FORMULATION TECHNOLOGIES, LLC DBA PHARMAFORM
Executed: 2008-07-17
Assignee
HIGHLAND THERAPEUTICS INC.
72 SAULTER STREET, TORONTO, ONTARIO, M4M 2H7, CANADA
Covered Properties
(2)
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 27, 2020
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 051946/0625 →
Assignment of Assignor's Interest
Feb 27, 2020
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC DBA PHARMAFORM
Reel/Frame 051946/0725 →
Assignment of Assignor's Interest
Feb 27, 2020
From: HIGHLAND THERAPEUTICS INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 051946/0980 →
Patent Security Agreement
Sep 3, 2024
From: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 068826/0711 →
Security Interest
Dec 23, 2025
From: COLLEGIUM PHARMACEUTICAL, INC.; BIODELIVERY SCIENCES INTERNATIONAL, INC.; IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
To: TRUIST BANK, A NORTH CAROLINA CHARTERED BANK
Reel/Frame 073302/0334 →
Release of Security Interest
Dec 23, 2025
From: BIOPHARMA CREDIT PLC
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 073308/0416 →